Zurueck zur Suche

Reporte zur Charge UJ836AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

8Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TX 3 PA 2 MA 1 CA 1

VAERS 2716480

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ836AA

gering
Staat
MA
Alter
0,2
Geschlecht
U
Eingang
21.11.2023
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Medication error No adverse event

Symptomtext

2-month-old baby was administered a hip shot of an expired ACTHIB with no adverse event; Initial information received on 16-Nov-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 2 months old and unknown gender patient who was administered a hip shot of an expired HIB (PRP/T) Vaccine [ACT-HIB] with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received an expired dose of suspect HIB (PRP/T) Vaccine Powder and solvent for solution for injection (lot UJ836AA, Expiry date: 20-10-2023 with unknown strength) via unknown route in unknown administration site as immunization with no adverse event (expired product administered) (latency: same day). This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2714293

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ836AA

gering
Staat
TX
Alter
1,0
Geschlecht
F
Eingang
15.11.2023
Impfdatum
01.11.2023
Beginn
01.11.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

an expired dose of ACTHIB was given to a patient with no reported adverse event; Initial information received on 01-Nov-2023 regarding an unsolicited valid non-serious case received from a health professional. This case involves a 1 years old female patient who received an expired dose of Hib (Prp/T) Vaccine [Act-Hib], was given to a patient, with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 01-Nov-2023, the patient received an expired dose of suspect Hib (Prp/T) Vaccine (Powder and solvent for solution for injection), with no reported adverse event (expired product administered) (latency: same day) (strength: unknown) (lot: UJ836AA, Expiry date: 28-Oct-2023) via intramuscular route in unknown administration site for immunization. No lab data reported. Action taken : not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2712270

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ836AA

gering
Staat
PA
Alter
0,7
Geschlecht
M
Eingang
09.11.2023
Impfdatum
30.10.2023
Beginn
30.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

expired acthib was given to a consumer with no reported adverse event; Initial information was received on 30-Oct-2023 regarding an unsolicited valid non-serious case received from a nurse. This case involves a 8 months old male patient to whom expired HIB (PRP/T) vaccine [ACT-HIB] was given with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included diphtheria vaccine toxoid, hepatitis b vaccine rhbsag (yeast), pertussis vaccine acellular 3-component, polio vaccine inact 3v (vero), tetanus vaccine toxoid (pediarix), pneumococcal vaccine 13v (pneumococcal 13 valent vaccine) and influenza vaccine (influenza) for prophylactic vaccination. On 30-Oct-2023, the patient received a 0.5 ml, (once) dose of suspect HIB (PRP/T) vaccine (Powder and solvent for solution for injection) (lot UJ836AA, expiry date: 28-Oct-2023, strength: standard) via intramuscular route in the left thigh for Immunisation and expired acthib was given to a consumer with no reported adverse event (expired product administered) (Latency: same day). Action taken: not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
PEDIARIX; PNEUMOCOCCAL 13 VALENT VACCINE; INFLUENZA
Allergien
-
Vorherige Impfungen
-

VAERS 2708686

SANOFI PASTEUR · HIB (ACTHIB) · Charge uj836aa

gering
Staat
-
Alter
0,8
Geschlecht
M
Eingang
02.11.2023
Impfdatum
02.11.2023
Beginn
02.11.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

expired vaccine administration

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2708493

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ836AA

gering
Staat
CA
Alter
1,0
Geschlecht
F
Eingang
01.11.2023
Impfdatum
31.10.2023
Beginn
01.11.2023
Tage bis Beginn
1,0
Dosis
4
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

Patient was given an expired vaccine. Vaccine expired 10/28/2023. No known adverse effects.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
See above
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None.
Allergien
None.
Vorherige Impfungen
-

VAERS 2708130

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ836AA

gering
Staat
PA
Alter
0,7
Geschlecht
M
Eingang
01.11.2023
Impfdatum
30.10.2023
Beginn
30.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event

Symptomtext

Patient had no adverse reaction

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
Umbilical hernia without obstruction and without gangrene
Andere Medikamente
N/A
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2647013

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ836AA

gering
Staat
TX
Alter
0,3
Geschlecht
M
Eingang
19.06.2023
Impfdatum
13.06.2023
Beginn
13.06.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Medication error No adverse event

Symptomtext

extra dose of ACTHIB was administered with no reported adverse event; Initial information received on 14-Jun-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves 4 months old male patient who was administered an extra dose of haemophilus type B (HIB) (PRP/T) vaccine [ACT-HIB] with no reported adverse event The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included diphtheria vaccine toxoid, hepatitis B Vaccine RHBSAG (YEAST), HIB VACCINE CONJ (menigococcal protein), pertussis vaccine acellular 5-component, polio vaccine inact 3V (VERO), tetanus vaccine toxoid (Vaxelis) for Prophylactic vaccination; pneumococcal vaccine conj 13V (CRM197) (Prevnar 13) for Prophylactic vaccination; and rotavirus vaccine live oral 1V (Rotarix) for Prophylactic vaccination. On 13-Jun-2023, the patient received a Standard dose of suspect haemophilus type B (HIB) (PRP/T) vaccine Powder and solvent for solution for injection at a dose of 0.5 mL total (lot UJ836AA, expiry date- 28-OCT-2023) via intramuscular route in the right thigh for Immunization. On 13-Jun-2023, (latency- same day), the patient developed a non-serious event of extra dose was administered with no reported adverse event (extra dose administered) following the administration of haemophilus type B (HIB) (PRP/T) vaccine. Reportedly, HCP called to inform that a medical assistant gave an extra dose of ACTHIB. As per the caller, the medical assistant thought that the VAXELIS did not contain the components of ACTHIB and gave an extra dose of ACTHIB to the patient. Action taken was not applicable. At time of reporting, the outcome was Unknown for the event This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2644761

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ836AA

gering
Staat
TX
Alter
0,3
Geschlecht
M
Eingang
13.06.2023
Impfdatum
13.06.2023
Beginn
13.06.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered

Symptomtext

Extra dose of HIB was administered by medical assistant. Patient was contacted by Provider. No symptoms

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
NA
Vorgeschichte
NA
Andere Medikamente
NA
Allergien
na
Vorherige Impfungen
-